US Stock MarketDetailed Quotes

ProQR Therapeutics (PRQR)

Watchlist
  • 1.850
  • -0.130-6.57%
Close Apr 10 16:00 ET
  • 1.840
  • -0.010-0.54%
Post 19:11 ET
194.92MMarket Cap-3.95P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ProQR Therapeutics (PRQR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-45.06%-52.79M
-42.89%-13.36M
-116.28%-12.24M
-82.24%-11.4M
-4.40%-15.8M
-268.89%-36.39M
-75.65%-9.35M
24.65%-5.66M
39.54%-6.26M
-133.83%-15.13M
Net income from continuing operations
-51.94%-42.18M
4.14%-8.92M
-35.74%-11.01M
-352.41%-12.18M
-31.61%-10.08M
-0.10%-27.76M
-69.71%-9.31M
-49.59%-8.11M
66.25%-2.69M
13.52%-7.66M
Operating gains losses
31.88%-235K
25.32%-59K
101.44%2K
153.33%104K
-514.71%-282K
68.17%-345K
-104.11%-79K
91.34%-139K
11.76%-195K
110.15%68K
Depreciation and amortization
-2.10%2.7M
1.19%679K
-2.47%671K
-5.06%675K
-1.88%678K
9.87%2.76M
-7.83%671K
7.17%688K
19.70%711K
25.87%691K
Deferred tax
109.64%19K
--1K
--0
109.00%18K
--0
-152.56%-197K
--0
--0
---200K
--3K
Other non cash items
47.03%-1.49M
89.01%-147K
33.26%-313K
42.11%-297K
-49.59%-730K
53.31%-2.81M
76.64%-1.34M
-29.20%-469K
10.16%-513K
-458.82%-488K
Change In working capital
-31.31%-17.42M
-1,086.56%-6.44M
-375.20%-3.07M
74.47%-1.18M
27.14%-6.72M
-127.09%-13.26M
-123.65%-543K
155.63%1.12M
-27.39%-4.61M
-117.64%-9.22M
-Change in other working capital
-31.31%-17.42M
-1,086.56%-6.44M
-375.20%-3.07M
74.47%-1.18M
27.14%-6.72M
-127.09%-13.26M
-123.65%-543K
155.63%1.12M
-27.39%-4.61M
-117.64%-9.22M
Cash from discontinued investing activities
Operating cash flow
-45.06%-52.79M
-42.89%-13.36M
-116.28%-12.24M
-82.24%-11.4M
-4.40%-15.8M
-268.89%-36.39M
-75.65%-9.35M
24.65%-5.66M
39.54%-6.26M
-133.83%-15.13M
Investing cash flow
Cash flow from continuing investing activities
74.96%-1.02M
81.13%-526K
-101.01%-169K
62.17%-101K
98.74%-224K
-195.21%-4.07M
-155.76%-2.79M
5,030.38%16.71M
9.18%-267K
-19,823.60%-17.73M
Net PPE purchase and sale
28.07%-1.02M
-295.49%-526K
40.91%-169K
62.17%-101K
69.40%-224K
-8.16%-1.42M
77.42%-133K
15.63%-286K
9.18%-267K
-722.47%-732K
Net intangibles purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
--0
--0
--0
--0
--0
--0
--0
--17M
--0
---17M
Net other investing changes
----
----
----
----
----
-12.93%-2.66M
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
74.96%-1.02M
81.13%-526K
-101.01%-169K
62.17%-101K
98.74%-224K
-195.21%-4.07M
-155.76%-2.79M
5,030.38%16.71M
9.18%-267K
-19,823.60%-17.73M
Financing cash flow
Cash flow from continuing financing activities
-102.61%-1.84M
-100.84%-599K
1.99%-444K
-3.90%-293K
-19.33%-500K
3,189.05%70.28M
6,641.21%71.43M
-61.21%-453K
56.14%-282K
-61.78%-419K
Net issuance payments of debt
-20.42%-1.91M
-137.55%-601K
2.20%-444K
0.34%-293K
2.41%-567K
39.83%-1.58M
80.40%-253K
-5.09%-454K
54.56%-294K
-124.32%-581K
Net common stock issuance
--0
----
----
----
----
--71.64M
----
----
----
----
Proceeds from stock option exercised by employees
-69.06%69K
-95.83%2K
--0
--0
-58.64%67K
-37.01%223K
-75.88%48K
-99.34%1K
200.00%12K
--162K
Cash from discontinued financing activities
Financing cash flow
-102.61%-1.84M
-100.84%-599K
1.99%-444K
-3.90%-293K
-19.33%-500K
3,189.05%70.28M
6,641.21%71.43M
-61.21%-453K
56.14%-282K
-61.78%-419K
Net cash flow
Beginning cash position
25.63%149.41M
19.55%106.88M
51.66%119.77M
54.49%132.41M
25.63%149.41M
25.48%118.93M
-25.84%89.4M
-38.57%78.97M
-38.33%85.71M
25.48%118.93M
Current changes in cash
-286.67%-55.65M
-124.42%-14.48M
-221.16%-12.85M
-73.33%-11.8M
50.36%-16.52M
26.58%29.81M
4,293.35%59.29M
230.46%10.6M
39.69%-6.81M
-175.00%-33.28M
Effect of exchange rate changes
-300.30%-1.35M
-98.32%12K
80.35%-34K
-1,477.42%-854K
-764.79%-472K
12.35%673K
434.74%713K
-246.61%-173K
-92.79%62K
142.77%71K
End cash Position
-38.15%92.41M
-38.15%92.41M
19.55%106.88M
51.66%119.77M
54.49%132.41M
25.63%149.41M
25.63%149.41M
-25.84%89.4M
-38.57%78.97M
-38.33%85.71M
Free cash flow
-42.32%-53.81M
-46.43%-13.88M
-108.72%-12.4M
-76.33%-11.5M
-1.00%-16.02M
-287.40%-37.81M
-60.04%-9.48M
24.26%-5.94M
38.70%-6.52M
-135.58%-15.86M
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -45.06%-52.79M-42.89%-13.36M-116.28%-12.24M-82.24%-11.4M-4.40%-15.8M-268.89%-36.39M-75.65%-9.35M24.65%-5.66M39.54%-6.26M-133.83%-15.13M
Net income from continuing operations -51.94%-42.18M4.14%-8.92M-35.74%-11.01M-352.41%-12.18M-31.61%-10.08M-0.10%-27.76M-69.71%-9.31M-49.59%-8.11M66.25%-2.69M13.52%-7.66M
Operating gains losses 31.88%-235K25.32%-59K101.44%2K153.33%104K-514.71%-282K68.17%-345K-104.11%-79K91.34%-139K11.76%-195K110.15%68K
Depreciation and amortization -2.10%2.7M1.19%679K-2.47%671K-5.06%675K-1.88%678K9.87%2.76M-7.83%671K7.17%688K19.70%711K25.87%691K
Deferred tax 109.64%19K--1K--0109.00%18K--0-152.56%-197K--0--0---200K--3K
Other non cash items 47.03%-1.49M89.01%-147K33.26%-313K42.11%-297K-49.59%-730K53.31%-2.81M76.64%-1.34M-29.20%-469K10.16%-513K-458.82%-488K
Change In working capital -31.31%-17.42M-1,086.56%-6.44M-375.20%-3.07M74.47%-1.18M27.14%-6.72M-127.09%-13.26M-123.65%-543K155.63%1.12M-27.39%-4.61M-117.64%-9.22M
-Change in other working capital -31.31%-17.42M-1,086.56%-6.44M-375.20%-3.07M74.47%-1.18M27.14%-6.72M-127.09%-13.26M-123.65%-543K155.63%1.12M-27.39%-4.61M-117.64%-9.22M
Cash from discontinued investing activities
Operating cash flow -45.06%-52.79M-42.89%-13.36M-116.28%-12.24M-82.24%-11.4M-4.40%-15.8M-268.89%-36.39M-75.65%-9.35M24.65%-5.66M39.54%-6.26M-133.83%-15.13M
Investing cash flow
Cash flow from continuing investing activities 74.96%-1.02M81.13%-526K-101.01%-169K62.17%-101K98.74%-224K-195.21%-4.07M-155.76%-2.79M5,030.38%16.71M9.18%-267K-19,823.60%-17.73M
Net PPE purchase and sale 28.07%-1.02M-295.49%-526K40.91%-169K62.17%-101K69.40%-224K-8.16%-1.42M77.42%-133K15.63%-286K9.18%-267K-722.47%-732K
Net intangibles purchase and sale --0------------------0----------------
Net investment purchase and sale --0--0--0--0--0--0--0--17M--0---17M
Net other investing changes ---------------------12.93%-2.66M----------------
Cash from discontinued investing activities
Investing cash flow 74.96%-1.02M81.13%-526K-101.01%-169K62.17%-101K98.74%-224K-195.21%-4.07M-155.76%-2.79M5,030.38%16.71M9.18%-267K-19,823.60%-17.73M
Financing cash flow
Cash flow from continuing financing activities -102.61%-1.84M-100.84%-599K1.99%-444K-3.90%-293K-19.33%-500K3,189.05%70.28M6,641.21%71.43M-61.21%-453K56.14%-282K-61.78%-419K
Net issuance payments of debt -20.42%-1.91M-137.55%-601K2.20%-444K0.34%-293K2.41%-567K39.83%-1.58M80.40%-253K-5.09%-454K54.56%-294K-124.32%-581K
Net common stock issuance --0------------------71.64M----------------
Proceeds from stock option exercised by employees -69.06%69K-95.83%2K--0--0-58.64%67K-37.01%223K-75.88%48K-99.34%1K200.00%12K--162K
Cash from discontinued financing activities
Financing cash flow -102.61%-1.84M-100.84%-599K1.99%-444K-3.90%-293K-19.33%-500K3,189.05%70.28M6,641.21%71.43M-61.21%-453K56.14%-282K-61.78%-419K
Net cash flow
Beginning cash position 25.63%149.41M19.55%106.88M51.66%119.77M54.49%132.41M25.63%149.41M25.48%118.93M-25.84%89.4M-38.57%78.97M-38.33%85.71M25.48%118.93M
Current changes in cash -286.67%-55.65M-124.42%-14.48M-221.16%-12.85M-73.33%-11.8M50.36%-16.52M26.58%29.81M4,293.35%59.29M230.46%10.6M39.69%-6.81M-175.00%-33.28M
Effect of exchange rate changes -300.30%-1.35M-98.32%12K80.35%-34K-1,477.42%-854K-764.79%-472K12.35%673K434.74%713K-246.61%-173K-92.79%62K142.77%71K
End cash Position -38.15%92.41M-38.15%92.41M19.55%106.88M51.66%119.77M54.49%132.41M25.63%149.41M25.63%149.41M-25.84%89.4M-38.57%78.97M-38.33%85.71M
Free cash flow -42.32%-53.81M-46.43%-13.88M-108.72%-12.4M-76.33%-11.5M-1.00%-16.02M-287.40%-37.81M-60.04%-9.48M24.26%-5.94M38.70%-6.52M-135.58%-15.86M
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.02%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.46%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+1.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+0.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.34%
Sample Name
Sample Code
 +11.49%
Sample Name
Sample Code
 +10.29%
4
Futu Holdings Ltd
FUTU
+10.23%
5
Hesai
HSAI
+9.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -